Abstract
Previous investigations into potential transforming activities of adenovirus (Ad) early genes were largely overshadowed by the more obvious roles of E1A and E1B products. One exception was an Ad9 E4 protein (ORF1) shown to enhance transformation of cultured cells and promote mammary tumors in female rats. Recently, significant advances in understanding Ad E4 gene products at the molecular level have revealed that these proteins possess an unexpectedly diverse collection of functions, which not only orchestrate many viral processes, but overlap with oncogenic transformation of primary mammalian cells. Operating through a complex network of protein interactions with key viral and cellular regulatory components, Ad E4 products are apparently involved in transcription, apoptosis, cell cycle control, DNA repair, cell signaling, posttranslational modifications and the integrity of nuclear multiprotein complexes known as PML oncogenic domains (PODs). Some of these functions directly relate to known transforming and oncogenic processes, or implicate mechanisms such as modulating the function and subcellular localization of cellular PDZ domain-containing proteins, POD reorganization, targeted proteolytic degradation, inhibition of DNA double-strand break repair and ‘hit-and-run’ mutagenesis. Here, we summarize the recent data and discuss how E4 gene product interactions may contribute to viral oncogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ankerst J, Jonsson N . 1989 J. Natl. Cancer Inst. 81: 294–298
Ankerst J, Jonsson N, Kjellen L, Norrby E, Sjogren HO . 1974 Int. J. Cancer 13: 286–290
Bernards R, de Leeuw MG, Vaessen MJ, Houweling A, van der Eb AJ . 1984 J. Virol. 50: 847–853
Boyer JL, Ketner G . 2000 J. Biol. Chem. 275: 14969–14978
Boyer JL, Rohleder K, Ketner G . 1999 Virology 263: 307–312
Brackmann KH, Green M, Wold WS, Cartas M, Matsuo T, Hashimoto S . 1980 J. Biol. Chem. 255: 6772–6779
Bridge E, Ketner G . 1989 J. Virol. 63: 631–638
Bridge E, Ketner G . 1990 Virology 174: 345–353
Carvalho T, Seeler JS, Öhman K, Jordan P, Pettersson U, Akusjärvi G, Carmo Fonseca M, Dejean A . 1995 J. Cell. Biol. 131: 45–56
Cathomen T, Weitzman MD . 2000 J. Virol. 74: 11407–11412
Cress WD, Nevins JR . 1996a Mol. Cell. Biol. 16: 2119–2127
Cress WD, Nevins JR . 1996b Curr. Top. Microbiol. Immunol. 208: 63–78
Cutt JR, Shenk T, Hearing P . 1987 J. Virol. 61: 543–552
Dix I, Leppard KN . 1995 J. Gen. Virol. 76: 1051–1055
Dobbelstein M, Roth J, Kimberly WT, Levine AJ, Shenk T . 1997 EMBO J. 16: 4276–4284
Dobner T, Horikoshi N, Rubenwolf S, Shenk T . 1996 Science 272: 1470–1473
Dobner T, Kzhyshkowska J . 2001 Curr. Top. Microbiol. Immunol. 259: 25–54
Doucas V, Ishov AM, Romo A, Juguilon H, Weitzman MD, Evans RM, Maul GG . 1996 Genes Dev. 10: 196–207
Downey JF, Rowe DT, Bacchetti S, Graham FL, Bayley ST . 1983 J. Virol. 45: 514–523
Esche H . 1982 J. Virol. 41: 1076–1082
Esche H, Schilling R, Dörfler W . 1979 J. Virol. 30: 21–31
Esche H, Siegman B . 1982 J. Gen. Virol. 60: 99–113
Fanning AS, Anderson JM . 1999 J. Clin. Invest. 103: 767–772
Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin Jr WG, Livingston DM, Orkin SH, Greenberg ME . 1996 Cell 85: 549–561
Flint SJ, Gallimore PH, Sharp PA . 1975 J. Mol. Biol. 96: 47–68
Flint SJ, Sambrook J, Williams JF, Sharp PA . 1976 Virology 72: 456–470
Flint SJ, Sharp PA . 1976 J. Mol. Biol. 106: 749–771
Freyer GA, Katoh Y, Roberts RJ . 1984 Nucl. Acids Res. 12: 3503–3519
Gardiol D, Kuhne C, Glaunsinger BA, Lee SS, Javier RT, Banks L . 1999 Oncogene 18: 5487–5496
Glaunsinger BA, Lee SS, Thomas M, Banks L, Javier RT . 2000 Oncogene 19: 5270–5280
Goodrum FD, Ornelles DA . 1999 J. Virol. 73: 7474–7488
Goodrum FD, Shenk T, Ornelles DA . 1996 J. Virol. 70: 6323–6335
Graham FL . 1984 The adenoviruses. Ginsberg HS (ed) Plenum Press: New York pp 339–398
Grand RJ, Grant ML, Gallimore PH . 1994 Virology 203: 229–240
Grifman M, Chen NN, Gao G, Cathomen T, Wilson JM, Weitzman MD . 1999 J. Virol. 73: 10010–10019
Halbert DN, Cutt JR, Shenk T . 1985 J. Virol. 56: 250–257
Hardy S, Engel DA, Shenk T . 1989 Genes Dev. 3: 1062–1074
Hardy S, Shenk T . 1989 Mol. Cell. Biol. 9: 4495–4506
Herisse J, Rigolet M, de Dinechin SD, Galibert F . 1981 Nucl. Acids Res. 9: 4023–4042
Horwitz MS . 1996 Virology Vol. 2. Fields BN, Knipe DM and Howley PM (eds). Lippincott-Raven: New York pp 2149–2171
Huang MM, Hearing P . 1989a J. Virol. 63: 2605–2615
Huang MM, Hearing P . 1989b Genes Dev. 3: 1699–1710
Javier RT . 1994 J. Virol. 68: 3917–3924
Javier RT, Raska Jr K, Macdonald GJ, Shenk T . 1991 J. Virol. 65: 3192–3202
Javier RT, Raska Jr K, Shenk T . 1992 Science 257: 1267–1271
Javier RT, Shenk T . 1996 Breast Cancer Res. Treatment 39: 57–67
Johnson DG, Cress WD, Jakoi L, Nevins JR . 1994 Proc. Natl. Acad. Sci. USA 91: 12823–12827
Jonsson N, Ankerst J . 1977 Cancer 39: 2513–2519
Kleinberger T . 2000 Apoptosis 5: 211–215
Kleinberger T, Shenk T . 1993 J. Virol. 67: 7556–7560
König C, Roth J, Dobbelstein M . 1999 J. Virol. 73: 2253–2262
Kovesdi I, Reichel R, Nevins JR . 1986a Science 231: 719–722
Kovesdi I, Reichel R, Nevins JR . 1986b Cell 45: 219–228
Kovesdi I, Reichel R, Nevins JR . 1987 Proc. Natl. Acad. Sci. USA 84: 2180–2184
Lee SS, Glaunsinger BA, Mantovani F, Banks L, Javier RT . 2000 J. Virol. 74: 9680–9693
Lee SS, Weiss RS, Javier RT . 1997 Proc. Natl. Acad. Sci. USA 94: 6670–6675
Leppard KN, Everett RD . 1999 J. Gen. Virol. 80: 997–1008
Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM . 1999 Proc. Natl. Acad. Sci. USA 96: 11364–11369
Marton MJ, Baim SB, Ornelles DA, Shenk T . 1990 J. Virol. 64: 2345–2359
Moore M, Horikoshi N, Shenk T . 1996 Proc. Natl. Acad. Sci. USA 93: 11295–11301
Neill SD, Hemstrom C, Virtanen A, Nevins JR . 1990 Proc. Natl. Acad. Sci. USA 87: 2008–2012
Neill SD, Nevins JR . 1991 J. Virol. 65: 5364–5373
Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T . 1997 Proc. Natl. Acad. Sci. USA 94: 1206–1211
Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T . 2000 J. Virol. 74: 5168–5181
Nevels M, Spruss T, Wolf H, Dobner T . 1999a Oncogene 18: 9–17
Nevels M, Täuber B, Kremmer E, Spruss T, Wolf H, Dobner T . 1999b J. Virol. 73: 1591–1600
Nevels M, Täuber B, Spruss T, Wolf H, Dobner T . 2001 J. Virol. 75: 3089–3094
Nevins JR, Vogt PK . 1996 Virology Vol. 1: Fields Virology. Fields BN, Knipe DM and Howley PM (eds). Lippincott-Raven: New York pp 301–343
Nicolás AL, Munz PL, Falck-Pedersen E, Young CSH . 2000 Virology 266: 211–224
O'Connor RJ, Hearing P . 1991 Nucl. Acids Res. 19: 6579–6586
O'Connor RJ, Hearing P . 2000 J. Virol. 74: 5819–5824
Obert S, O'Connor RJ, Schmid S, Hearing P . 1994 Mol. Cell. Biol. 14: 1333–1346
Öhman K, Nordquist K, Linder S, Akusjärvi G . 1995 Int. J. Oncol. 6: 663–668
Orlando JS, Ornelles DA . 1999 J. Virol. 73: 4600–4610
Ornelles DA, Shenk T . 1991 J. Virol. 65: 424–429
Puvion-Dutilleul F, Chelbi-Alix MK, Koken M, Quignon F, Puvion E, de The H . 1995 Exp. Cell. Res. 218: 9–16
Querido E, Marcellus RC, Lai A, Rachel C, Teodoro JG, Ketner G, Branton PE . 1997 J. Virol. 71: 3788–3798
Querido E, Morisson MR, Chu-Pham-Dang H, Thirlwell SW, Boivin D, Branton PE . 2001 J. Virol. 75: 699–709
Raychaudhuri P, Bagchi S, Nevins JR . 1989 Genes Dev. 3: 620–627
Reichel R, Neill SD, Kovesdi I, Simon MC, Raychaudhuri P, Nevins JR . 1989 J. Virol. 63: 3643–3650
Roth J, König C, Wienzek S, Weigel S, Ristea S, Dobbelstein M . 1998 J. Virol. 72: 8510–8516
Sarnow P, Hearing P, Anderson CW, Halbert DN, Shenk T, Levine AJ . 1984 J. Virol. 49: 692–700
Sarnow P, Hearing P, Anderson CW, Reich N, Levine AJ . 1982 J. Mol. Biol. 162: 565–583
Schaley J, O'Connor RJ, Taylor LJ, Bar-Sagi D, Hearing P . 2000 J. Virol. 74: 2084–2093
Shiroki K, Hashimoto S, Saito I, Fukui Y, Kato H, Shimojo H . 1984 J. Virol. 50: 854–863
Singh P, Wong SH, Hong W . 1994 EMBO J. 13: 3329–3338
Smith GCM, Jackson SP . 1999 Genes Dev. 13: 916–934
Steegenga WT, Riteco N, Jochemsen AG, Fallaux FJ, Bos JL . 1998 Oncogene 16: 349–357
Täuber B, Dobner T . 2001 Gene in press
Terris B, Baldin V, Dubois S, Degott C, Flejou J-F, Hénin D, Dejean A . 1995 Cancer Res. 55: 1590–1597
Thomas DL, Schaack J, Vogel H, Javier RT . 2001 J. Virol. 75: 557–568
Thomas DL, Shin S, Jiang BH, Vogel H, Ross MA, Kaplitt M, Shenk TE, Javier RT . 1999 J. Virol. 73: 3071–3079
Trentin JJ, Yabe Y, Taylor G . 1962 Science 137: 835–849
Virtanen A, Gilardi P, Naslund A, LeMoullec JM, Pettersson U, Perricaudet M . 1984 J. Virol. 51: 822–831
Weiden MD, Ginsberg HS . 1994 Proc. Natl. Acad. Sci. USA 91: 153–157
Weiss RS, Javier RT . 1997 J. Virol. 71: 7873–7880
Weiss RS, Gold MO, Vogel H, Javier RT . 1997a J. Virol. 71: 4385–4394
Weiss RS, Lee SS, Prasad BV, Javier RT . 1997b J. Virol. 71: 1857–1870
Weiss RS, McArthur MJ, Javier RT . 1996 J. Virol. 70: 862–872
Wienzek S, Dobbelstein M . 2001 J. Virol. 75: 5391–5397
Wienzek S, Roth J, Dobbelstein M . 2000 J. Virol. 74: 193–202
Xu G, Livingston DM, Krek W . 1995 Proc. Natl. Acad. Sci. USA 92: 1357–1361
Yamano S, Tokino T, Yasuda M, Kaneuchi M, Takahashi M, Niitsu Y, Fujinaga K, Yamashita T . 1999 J. Virol. 73: 10095–10103
Zalmanzon ES . 1987 Eksp. Onkol. 9: 3–8
Zheng P, Guo Y, Niu Q, Levy DE, Dyck JA, Lu S, Sheiman LA, Liu Y . 1998 Nature 396: 373–376
Zhong S, Hu P, Ye TZ, Stan R, Ellis NA, Pandolfi PP . 1999 Oncogene 18: 7941–7947
Acknowledgements
We are most grateful to Avril Arthur for critically reading the manuscript and Phil Branton for providing unpublished information. Work in this laboratory was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and from the Fonds der Chemischen Industrie (FCI) to T Dobner.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Täuber, B., Dobner, T. Adenovirus early E4 genes in viral oncogenesis. Oncogene 20, 7847–7854 (2001). https://doi.org/10.1038/sj.onc.1204914
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204914
Keywords
This article is cited by
-
Genetic Analysis of Human Adenovirus Type 7 Strains Circulating in Different Parts of China
Virologica Sinica (2021)
-
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
Nature Biotechnology (2020)
-
A prospect of cell immortalization combined with matrix microenvironmental optimization strategy for tissue engineering and regeneration
Cell & Bioscience (2019)
-
Molecular Evolution of Human Adenovirus (HAdV) Species C
Scientific Reports (2019)
-
Epigenetic mechanisms in virus-induced tumorigenesis
Clinical Epigenetics (2011)